Vaxart, Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic
Vaxart, Inc. (VXRT) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of $14.70 million for the 12-month period ending 2025-12-31, per its S-1 filed 2026-05-08.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-05-08
- Vaxart, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2017 was -$5.10M.
- Vaxart, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2016 was -$4.90M.
- Vaxart, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2015 was -$26.70M.
- Vaxart, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2014 was -$8.30M, a 227.69% decline from fiscal 2013.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month as first filed |
|---|---|---|
| 2025-12-31 | $14.70M S-1 · filed 2026-05-08 | |
| 2024-12-31 | -$67.49M S-1 · filed 2026-05-08 | |
| 2017-06-30 | -$5.10M 10-K · filed 2017-09-01 | |
| 2016-06-30 | -$4.90M 10-K · filed 2017-09-01 | |
| 2015-06-30 | -$26.70M 10-K · filed 2016-09-13 | |
| 2014-06-30 | -$8.30M 10-K · filed 2016-09-13 | |
| 2013-06-30 | $6.50M 10-K · filed 2015-09-11 | $6.70M 10-K · filed 2013-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |